Virginia Retirement Systems Et Al Supernus Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 20,400 shares of SUPN stock, worth $725,628. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,400

Previous 18,400 10.87%

Holding current value

$725,628

Previous $553,000 1.63%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$27.57 - $32.91 $55,140 - $65,820	2,000 Added 10.87%	20,400 $562,000
Q2 2023 Aug 22, 2023	BUY	$29.91 - $38.73 $550,344 - $712,632	18,400 New	18,400 $553,000
Q1 2022 Apr 21, 2022	SELL	$28.51 - $32.9 $359,226 - $414,540	-12,600 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$26.37 - $34.22 $282,159 - $366,154	-10,700 Reduced 45.92%	12,600 $367,000
Q3 2021 Oct 21, 2021	SELL	$23.54 - $31.39 $129,470 - $172,645	-5,500 Reduced 19.1%	23,300 $621,000
Q2 2021 Aug 13, 2021	SELL	$26.72 - $33.19 $61,456 - $76,337	-2,300 Reduced 7.4%	28,800 $887,000
Q1 2021 Apr 30, 2021	SELL	$24.15 - $31.45 $101,430 - $132,090	-4,200 Reduced 11.9%	31,100 $814,000
Q4 2020 Feb 16, 2021	SELL	$17.7 - $25.81 $70,800 - $103,240	-4,000 Reduced 10.18%	35,300 $888,000
Q3 2020 Nov 12, 2020	SELL	$20.2 - $25.05 $26,260 - $32,565	-1,300 Reduced 3.2%	39,300 $819,000
Q2 2020 Aug 12, 2020	SELL	$17.09 - $24.89 $66,651 - $97,071	-3,900 Reduced 8.76%	40,600 $964,000
Q4 2019 Jan 27, 2020	BUY	$19.93 - $29.13 $1,993 - $2,913	100 Added 0.23%	44,500 $1.06 Million
Q3 2019 Oct 22, 2019	BUY	$25.47 - $33.37 $476,289 - $624,019	18,700 Added 72.76%	44,400 $1.22 Million
Q2 2019 Jul 26, 2019	SELL	$29.96 - $38.87 $251,664 - $326,508	-8,400 Reduced 24.63%	25,700 $850,000
Q1 2019 Apr 25, 2019	BUY	$32.77 - $41.99 $52,432 - $67,184	1,600 Added 4.92%	34,100 $1.2 Million
Q4 2018 Feb 07, 2019	BUY	$30.84 - $49.51 $493,440 - $792,160	16,000 Added 96.97%	32,500 $1.08 Million
Q3 2018 Nov 02, 2018	SELL	$42.7 - $56.55 $269,010 - $356,265	-6,300 Reduced 27.63%	16,500 $831,000
Q2 2018 Aug 03, 2018	BUY	$44.1 - $59.85 $1.01 Million - $1.36 Million	22,800 New	22,800 $1.37 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

61.1M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Supernus Pharmaceuticals, Inc. Transaction History